Being a focussed webinar, we are making every effort to ensure we reach the right audience. So request you to confirm your work details by filling in the below form:

Register through a short form submission process:

This episode will have Anjan Chakrabarti, Ph.D the VP & Head – Discovery Chemistry at Syngene International in the hot seat discussing how to build “great chemistry” in research partnerships, as well as share first-hand accounts of some key trends in Discovery Chemistry, precipitated by COVID-19.

Topics covered:

COVID-19 is affecting us all in a way none of us could have imagined possible just a month  ago.Work from home, social distancing and being in quarantine seem to be the new normal. Every company and individual is struggling to adapt to this reality.
In such a scenario,  enabling collaboration and unfettered exchange of ideas becomes all the more important. With that thought in mind,  we decided to  launch this weekly Live-Chat series. The chat involves a 45 minutes discussion on topics that are of importance to scientists and the scientific community at large, to help them move forward in these difficult times.

About Syngene Weekly Live Chat Series

Syngene reserves the right, at its discretion, to change, modify, add, or remove participation.

  • Elements that help build great chemistry in a strategic research partnership
  • Innovation in chemistry: Will non-traditional aspects of chemistry and newer platforms like PROTACs take centre-stage after COVID-19?
  • Role of chemistry in drug repurposing
  • Working through COVID-19: Strengthening supply chains, partnerships, and alternative chemistry programs
  • Benefits of an integrated discovery chemistry model in times of crisis (and otherwise)

© Syngene International Ltd.
Syngene International Ltd. Biocon Park, SEZ, Bommasandra Industrial Area - Phase - IV, Bangalore 560099 India

Host: Ashu Tandon | Chief Commercial Officer, Syngene

Ashu has 20 years’ experience in the global biopharmaceuticals industry which includes Sales and Account Management leadership across consulting & outsourcing services in Research & Development. He has a successful track record of building multi-million dollar deals across multiple industry verticals and geographies.

As a member of the Syngene's Executive Committee, he plays an important role in driving strategy as it relates to Commercial activities. Prior to joining Syngene, Ashu was at IQVIA (formerly QuintilesIMS), Infosys and Accenture.

Panelist: Anjan Chakrabarti, Ph.D | VP & Head – Discovery Chemistry, Syngene

Anjan has over 20 years' of global experience in drug discovery and been associated with organisations like Affymax and Albany Molecular Research Inc., (AMRI). He has experience in several therapeutic areas – hematology, oncology, antibacterial, anti-HIV, CNS & anti-inflammatory and has more than 25 patents & publications to his credit.

At Syngene he is responsible for leading over 800 scientists engaged in drug discovery in the Discovery Chemistry Group.